Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Cinnamon vs Dulaglutide: Cinnamon has the stronger overall evidence (6.8 vs 7/10); they're alternatives for manage blood sugar — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Cinnamon wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (2)
Outcomes where both Cinnamon and Dulaglutide have evidence — compare verdict strength side-by-side.
1000-6000mg (1-6g) cinnamon powder daily, or 250-500mg standardized extract; prefer Ceylon for regular use
with-meals
Ceylon cinnamon powder or standardized aqueous extract
Prescription-only, clinician-prescribed. Subcutaneous 0.75 mg once weekly to start, usually escalated to 1.5 mg; 3.0 mg and 4.5 mg once-weekly doses are available for additional glycemic lowering. DO NOT self-dose.
any
Subcutaneous once-weekly pen (Trulicity)
4-12 weeks
4-12 weeks
8-12 weeks
8-12 weeks
Weeks to months
Months to years
Months
Especially during initiation/escalation
The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials
Phytotherapy research : PTR (2024) · Meta analysis
Significant reduction in fasting blood sugar (SMD −1.32; 95% CI −1.77 to −0.87; p<0.001)
Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes
Nutrition reviews (2025) · Meta analysis
Improvements in glycemic and lipid biomarkers reported
Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression
Diabetes research and clinical practice (2019) · Meta analysis
Significant reduction in fasting blood glucose
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet (2019) · Rct · n=9901
Multicentre, double-blind, placebo-controlled cardiovascular-outcomes RCT: 9,901 patients aged ≥50 with type 2 diabetes, randomized to subcutaneous dulaglutide 1.5 mg/week or placebo at 371 sites in 24 countries
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Lancet Diabetes Endocrinol (2019) · Meta analysis
Meta-analysis of seven GLP-1 receptor agonist cardiovascular-outcomes trials (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony Outcomes, REWIND, PIONEER 6); 56,004 participants
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet (2019) · Rct · n=9901
Pre-specified exploratory analysis of the REWIND trial (9,901 participants) examining the renal component of the composite microvascular outcome
Cinnamon has a higher evidence score (6.8/10 vs 7/10) and wins in 2 of 3 categories.
For manage blood sugar, Cinnamon has a higher relevance score (88 vs 82).
No known interactions between Cinnamon and Dulaglutide have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.